Glympse Bio

About:

Glympse Bio is a biotechnology company that transforms disease detection and predict treatment response.

Website: http://www.glympsebio.com

Twitter/X: GlympseBio

Top Investors: Temasek Holdings, Alumni Ventures, Gilead Sciences, ARCH Venture Partners, CRV

Description:

Glympse Bio develops a powerful new paradigm in diagnostics to enable noninvasive and predictive monitoring of multiple human diseases. The company’s technology uses precisely engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. Glympse Bio’s platform technology was originally developed at MIT, and is founded by a team of world-renowned experts in nanomedicine and biomedical engineering.